Skip to main content

Radioiodinated Peptides and Growth Factors and Their Applications

  • Chapter
Radioiodination: Theory, Practice, and Biomedical Applications

Part of the book series: Developments in Nuclear Medicine ((DNUM,volume 21))

Abstract

The use of octadecasilyl silica and other resin columns (C18-, C8-, CN-, and phenyl resin) in the batch extraction of tissue homogenates provides a simple means of rapid purification of peptides from tissues or plasma. High acidity (5% formic acid, 1% trifluoroacetic acid, or 1 N HCl) inhibits the peptidase activity present in tissue. Immediate freezing and homogenization in cold dilute acid (pH 2) could preserve physiologically active peptides and inhibit the artificial generation of components. Polypropylene tubes, pipettes, and tips are more useful because many peptides are adsorbed to glass surface. Proteins with molecular weight greater than 40,000 are usually excluded by 6 to 10 nm pore of commercial resin. The high resolution of the separation technique is enhanced by using acidic solvent systems. At low pH, the absorption of peptides to the silica matrix is reduced, and column efficiency, in terms of peak shape and theoretical plates, is improved. In addition, hydrophobic and ion repairing agents, such as trifluoroacetic acid, are used to associate with the free amino groups, which become fully ionized at low pH. This increased affinity for the reverse phase support material permits separation of melanocyte stimulating hormone, melanocyte stimulating hormone, ACTH, calcitonin, cytochrome c, bovine serum albumin, bovine prolactin, and bovine growth hormones from brain tissue by a linear gradient of 20% to 60% acetonitrile containing 0.1% trifluoroacetic acid during a period of 2 hours. The solvent system also permits monitoring for ultraviolet light absorbance at 210 nm. Because of the volatility of the solvent, further separation and the processing of the biologically active peptide and evaluation by radioimmunoassay are possible.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Heldin, C.-H. and Westermark, B. , Growth factors: mechanism of action and relation to oncogenes, Cell,37, 9, 1984.

    Article  PubMed  CAS  Google Scholar 

  2. Todaro, G. J., De Larco, J. E. , and Fryling, C. M. , Sarcoma growth factor and other transforming peptides produced by human cells: interactions with membrane receptors, Fed Proc, 41, 2996, 1982.

    PubMed  CAS  Google Scholar 

  3. Moses, H. L. , Branum, E. L. , Proper, J. A., and Robinson, R. A., Transforming growth factor production by chemically transformed cells, Cancer Res, 41, 2842, 1981.

    PubMed  CAS  Google Scholar 

  4. Moses, H. L. , Childs, C. B., Halper, J., Shipley, G. D., and Tucker, R. F. , Role of transforming growth factors in neoplastic transformation, in Control of Cell Growth and Proliferation, Veneziale,C. M. , Ed., Van Nostrand Reinhold, New York, 1985, 147.

    Google Scholar 

  5. Holley, R. W. , Böhlen, P., Fava, R. , Baldwin, J. H., Kleeman, G., and Armour, R. , Purification of kidney epithelial cell growth inhibitors, Proc Natl Acad Sci USA. 77, 5989, 1980.

    Article  PubMed  CAS  Google Scholar 

  6. Holley, R. W. , Armour, R. , Baldwin, J. H. , and Greenfield, S., Preparation and properties of a growth inhibitor produced by kidney epithelial cells, Cell Biol Int Rep, 7, 525, 1983.

    Article  CAS  Google Scholar 

  7. Holley, R. W. , Armour, R. , Baldwin, J. H. , and Greenfield, S., Activity of a kidney epithelial cell growth inhibitor on lung and mammary cells, Cell Biol Int Rep, 7, 141, 1983.

    Article  PubMed  CAS  Google Scholar 

  8. Carpenter, G. and Cohen, S., 125I-labeled human epidermal growth factor: binding, internalization and degradation in human fibroblasts, J Cell Biol, 71, 159, 1976.

    Article  PubMed  CAS  Google Scholar 

  9. Fox, C. F., Linsley, P. S., and Wrann, M., Receptor remodeling and regulation in the action of epidermal growth factor, Fed Proc, 41, 2988, 1982.

    PubMed  CAS  Google Scholar 

  10. Reddi, A. H. , Extracellular matrix and development, in Extracellular Matrix Biochemistry, Piez, K. A. and Reddi, A. H. , Eds., Elsevier, New York, 1984, 375.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1992 Springer Science+Business Media New York

About this chapter

Cite this chapter

Dewanjee, M.K. (1992). Radioiodinated Peptides and Growth Factors and Their Applications. In: Radioiodination: Theory, Practice, and Biomedical Applications. Developments in Nuclear Medicine, vol 21. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-3508-9_14

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-3508-9_14

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-6556-3

  • Online ISBN: 978-1-4615-3508-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics